Hub City Times

Top Menu

  • Contact Us
  • E-Editions
  • Subscribe

Main Menu

  • Home
  • News
    • Around the County
    • Arts & Ent
    • Education
    • Government
    • Local
    • Police / Sheriff Calls
  • Covid 19
  • Opinion
  • Sports
    • Sports News
    • High School Sports Scores
    • Wisconsin Rapids Rafters
  • Coming Events
  • Business
  • Obits
  • Classifieds
  • Military Photos
  • Contact Us
  • E-Editions
  • Subscribe

logo

Hub City Times

  • Home
  • News
    • Around the County
    • Arts & Ent
    • Education
    • Government
    • Local
    • Police / Sheriff Calls
  • Covid 19
  • Opinion
  • Sports
    • Sports News
    • High School Sports Scores
    • Wisconsin Rapids Rafters
  • Coming Events
  • Business
  • Obits
  • Classifieds
  • Military Photos
FeaturedHealth
Home›Featured›Marshfield Clinic Health System is first in state to offer new heart failure treatment

Marshfield Clinic Health System is first in state to offer new heart failure treatment

By Hub City Times
January 7, 2021
221
0
Share:
Marshfield Clinic
Designed to address an unmet medical need in heart failure, the Barostim Neo was one of the first therapies to receive the FDA’s coveted Breakthrough Device Designation. Mac Bailey photo

For the City Times

MARSHFIELD – Marshfield Clinic Health System is the first health care system in Wisconsin and the second in the Midwest to implant what is deemed as the “world’s first neuromodulation device for heart failure treatment.”

Barostim Neo is a Food and Drug Administration-approved device which uses a novel mechanism to improve cardiovascular function. This pacemaker-like device is designed to electrically activate the baroreflex, the body’s main cardiovascular reflex, signaling the brain to regulate cardiovascular function. Barostim Therapy activates baroreceptors in the wall of the carotid artery and stimulates the afferent and efferent pathways of the autonomic nervous system. The brain responds to the therapy by modulating efferent pathways, to relax blood vessels, slow the heart rate and reduce fluid in the body via improved kidney function.

Kumar, Sanjay MD

Kumar

Electrophysiologist Dr. Sanjay Kumar and Vascular Surgeon Dr. Tahlia Weis successfully performed the first two procedures at Marshfield Medical Center in Marshfield.

“We are very excited to bring this innovative and cutting edge technology that will address the unmet needs in cardiovascular diseases in the community,” said Harry Singh, cardiovascular service line administrator.

The placement of the Barostim Neo requires a minimally-invasive procedure under general anesthesia and can be done in an electrophysiology laboratory or catheterization lab as an outpatient procedure. The patients are usually discharged the same day or the next day. Physiological effects include lower heart rate and lower blood pressure.

“This technology will improve patient outcomes, quality of life, and overall cardiovascular health via novel baroreceptor neuromodulation therapy,” said Dr. Milind Shah, medical director, cardiovascular service line. “Patients can experience an improved quality of life and a greater ability to do simple exercises, such as walking without discomfort.”

Weis, Tahlia MD PHD

Weis

Designed to address an unmet medical need in heart failure, the Barostim Neo was one of the first therapies to receive the FDA’s coveted Breakthrough Device Designation. This distinction is reserved for unique therapies that are intended to treat a life-threatening or irreversibly debilitating disease where there is no available treatment alternative.

For more information, call Marshfield Medical Center-Marshfield Cardiology at 715-387-5301 or Marshfield Medical Center-Weston Cardiology at 715-393-1220.

Tagsfirst in stateheart proceduremarshfield clinic
Previous Article

From the Wood County Health Department: Vaccine ...

Next Article

MACCI turns 75: A new beginning

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Related articles More from author

  • Marshfield Clinic
    Arts & Entertainment

    Adverse Childhood Experiences Study documentary being screened May 1

    April 23, 2017
    By Hub City Times
  • Health

    Study aims to ID genetic factors linked to blastomycosis

    March 2, 2017
    By Hub City Times
  • Health

    Free CPR session to be held at Marshfield Clinic Sept. 20

    September 6, 2017
    By Hub City Times
  • Health

    Preserving Pathways roundtable on health care to be held May 31

    May 18, 2017
    By Hub City Times
  • Scott Hebbring, Ph.D., research scientist Marshfield Clinic Research Foundation Center for Human Genetics
    Health

    Study: New approach helps identify possible novel uses for existing drugs

    April 14, 2015
    By Hub City Times
  • Marshfield Clinic
    Business

    Marshfield Clinic Board elects new officers

    January 14, 2015
    By Hub City Times

About Us


Hub City Times is published by Multi Media Channels LLC, N2919 County Road QQ Waupaca, WI 54981.

Timeline

  • January 23, 2021

    MACCI turns 75: Part III Changing names

  • January 21, 2021

    DNR confirms CWD in Wood County, renews baiting and feeding bans

  • January 20, 2021

    City seeks candidates for ethics board

  • January 19, 2021

    Marshfield Clinic scheduling COVID vaccinations to those 65 and older

  • January 19, 2021

    Wood County deputy and K-9 partner recognized

Find us on Facebook

Copyright © 2020 Multi Media Channels, All Rights Reserved. Designed by MMC Team Awesome
×